Volume 24, Number 12—December 2018
Research
CTX-M-65 Extended-Spectrum β-Lactamase–Producing Salmonella enterica Serotype Infantis, United States1
Table 2
Accession no.† | Year | Specimen source | Resistance profile | Plasmids | gyrA | parC | Hospitalized | Recent travel |
---|---|---|---|---|---|---|---|---|
SRR2485280 |
2012 |
Feces |
No resistance detected |
No replicons detected |
None |
Wt |
No |
No travel |
SRR4025941 |
2012 |
Feces |
CSuTCip(I)NalCotGen(I) |
IncFIB-like |
D87Y |
Wt |
No |
Peru, Bolivia, Ecuador, Chile |
SRR4019596 |
2014 |
Urine |
CSSuTFox(I)Cip(I)NalCot |
IncFIB-like |
D87Y |
Wt |
No |
No data |
SRR3185042 |
2014 |
Feces |
No resistance detected |
No replicons detected |
None |
Wt |
Yes |
No travel |
SRR2485289 | 2015 | Feces | No resistance detected | No replicons detected | None | Wt | No | No data |
*A, ampicillin; Aug, amoxicillin-clavulanic acid; C, chloramphenicol; Cip, ciprofloxacin; Cot, trimethoprim/sulfamethoxazole; Cx, ceftriaxone; Fox, cefoxitin; Gen, gentamicin; (I), intermediate susceptibility; Nal, nalidixic acid; S, streptomycin; Su, sulfisoxazole; T, tetracycline; Tio, ceftiofur.
†Accession numbers are the sequence read archive run identification numbers from the National Center for Biotechnology Information.
1Preliminary results from this analysis were presented at the International Salmonella and Salmonellosis Symposium, June 6–8, 2016, St. Malo, France, and at the International Association for Food Protection Annual Meeting, July 9–12, 2017, Tampa, Florida, USA.
Page created: November 20, 2018
Page updated: November 20, 2018
Page reviewed: November 20, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.